EIF4E and breast carcinoma: For instance, ribavirin, an antiviral guanosine analogue that competes with 5′-cap and inhibits eIF4E activity, inhibits the proliferation and clonogenic potential of breast cancer cell lines with elevated eIF4E levels [81,88].